Sleep Performance Digest - Issue #12 Promising

Sleep, Circadian Rhythms and Eating Disorders: What a New Systematic Review Found

Hiya Aidasani, Scientific Editor
Reincarn Science Team Reviewed by Hiya Aidasani, Scientific Editor · M.Tech Medical Biotechnology, IIT Hyderabad
Quick Answer

A systematic review published in Frontiers in Neuroendocrinology finds that individuals with eating disorders (anorexia nervosa, bulimia nervosa, and binge-eating disorder) consistently show poorer sleep quality, longer time to fall asleep, and more fragmented sleep than controls. Anorexia nervosa is associated with reduced REM sleep and slow-wave sleep. Across all three disorders, an evening chronotype - a shift toward later sleep and wake times - is observed. The relationship is bidirectional: disrupted eating patterns dysregulate circadian rhythms and sleep, while poor sleep worsens appetite regulation and eating disorder symptoms. Orexin, which governs both wakefulness and feeding behaviour, is a key mechanistic link. Verdict: Promising, though evidence quality is limited by the predominance of subjective sleep measures.

At a Glance
What was reviewedSleep and circadian rhythm parameters in anorexia nervosa, bulimia nervosa, and binge-eating disorder
MethodsCross-sectional and longitudinal studies; subjective questionnaires and objective measures (polysomnography, actigraphy)
Key findingPoorer sleep quality, fragmented sleep, and an evening chronotype across EDs; AN showed reduced REM and slow-wave sleep
MechanismBidirectional - disrupted eating dysregulates circadian rhythms; poor sleep disrupts appetite via orexin and metabolic signalling
Strongest abnormalities inAnorexia nervosa - reduced REM, reduced slow-wave sleep, more nighttime arousals
Key limitationMost studies used subjective sleep measures; heterogeneity prevented meta-analysis; predominantly female samples
3
eating disorders examined (AN, BN, BED)
2-way
bidirectional sleep-eating relationship
-REM
reduced REM and slow-wave sleep in anorexia nervosa
Evening
chronotype shift observed across ED populations

Background: Why Sleep and Eating Share Biology

Sleep and appetite are not independent systems. Both are governed by overlapping biological clocks, neuroendocrine signals, and autonomic nervous system states. Yet for most of medical research, they have been studied in silos - sleep researchers examining insomnia, eating disorder specialists examining food behaviour, rarely looking at the same underlying circadian machinery that controls both.

This systematic review in Frontiers in Neuroendocrinology is among the more comprehensive attempts to map what actually happens to sleep when someone has an eating disorder - and what happens to eating when someone consistently sleeps poorly. The answer, the review argues, is that they amplify each other through a shared biology.

What the Review Examined

The review analysed published cross-sectional and longitudinal studies that measured sleep and circadian rhythm parameters in individuals with a clinical diagnosis of anorexia nervosa (AN), bulimia nervosa (BN), or binge-eating disorder (BED). Sleep was assessed through both subjective methods (questionnaires such as the Pittsburgh Sleep Quality Index) and objective methods (polysomnography, actigraphy). Circadian parameters included chronotype (morningness-eveningness preference), sleep timing, and circadian phase markers.

What It Found: Sleep Across Three Eating Disorders

Across all three eating disorder categories, individuals reported or showed poorer sleep quality compared to controls. The pattern was consistent: more time needed to fall asleep, more nighttime awakenings or arousals, and a subjective experience of less restorative sleep. The magnitude and character of disruption varied by disorder.

Eating Disorder Sleep Quality Sleep Architecture Chronotype
Anorexia Nervosa (AN) Poorer than controls; most severe abnormalities across all EDs Reduced REM sleep and slow-wave sleep; increased nighttime arousals Higher evening chronotype
Bulimia Nervosa (BN) Poorer than controls; longer sleep onset latency More fragmented sleep; limited objective PSG data Higher evening chronotype
Binge-Eating Disorder (BED) Poorer than controls; more nighttime arousals Fragmented sleep; associated with elevated BMI and metabolic factors Higher evening chronotype

Anorexia nervosa showed the strongest objectively measured sleep abnormalities. This is notable because AN studies were more likely to include polysomnography data - meaning the reduced REM and slow-wave sleep findings in AN carry more evidential weight than the predominantly self-report findings in BN and BED.

The Circadian Picture: An Evening Shift Across All Three Disorders

One of the consistent cross-disorder findings was an elevation in evening chronotype - the tendency to prefer later bedtimes, later wake times, and to feel most alert in the evening or at night. This is not just a preference; chronotype reflects the timing of underlying circadian processes including core body temperature rhythms, cortisol peaks, and melatonin onset.

Why chronotype matters An evening chronotype in someone who has to function on a conventional schedule creates chronic circadian misalignment - going to bed and waking up out of phase with the body's internal clock. This is associated with reduced slow-wave sleep, fragmented sleep architecture, and impaired glucose metabolism. In eating disorder populations, this misalignment may compound the direct effects of disordered eating on sleep.

Whether the evening chronotype shift is a driver or a consequence of eating disorder pathology is not yet established. Longitudinal studies with circadian biomarkers are needed to understand the direction of causality.

The Mechanism: Orexin and the Bidirectional Loop

The review identifies orexin - also called hypocretin - as a key mechanistic candidate linking the two systems. Orexin is a neuropeptide produced in the lateral hypothalamus that promotes arousal, suppresses REM sleep, and regulates feeding behaviour and energy balance. It sits at the intersection of the systems disrupted in eating disorders.

In the orexin model, the bidirectionality works roughly as follows. Caloric restriction, erratic meal timing, and changes in energy availability alter orexin signalling - disrupting the sleep-wake cycle, suppressing REM sleep, and shifting circadian timing. At the same time, disrupted sleep impairs the neuroendocrine regulation of appetite: reduced slow-wave sleep is associated with elevated ghrelin (hunger hormone) and reduced leptin (satiety hormone), which can drive compensatory eating urges that worsen eating disorder symptoms.

The bidirectional loop, simplified Disordered eating disrupts circadian timing and orexin signalling, fragmenting sleep and reducing REM and slow-wave sleep. Fragmented sleep with reduced slow-wave sleep alters the hormones governing hunger and satiety, which intensifies eating disorder symptoms. Each cycle compounds the other.

BMI and metabolic state are additional contributors. In BED, for example, the elevated BMI common in this population is independently associated with sleep fragmentation and altered sleep architecture - making it difficult to disentangle the eating disorder's direct effect on sleep from its metabolic downstream effects.

Hiya's Perspective

From the Research Desk

This study reports meaningful results, but several limitations deserve attention. Most critically: the majority of included studies relied on subjective sleep assessment. Self-reported sleep quality from questionnaires does not always align with objective polysomnography findings, and in populations where body awareness and psychological state are themselves disordered, subjective reports require particular caution. The objective PSG data that do exist (predominantly from AN studies) are more compelling, but we need more of it across BN and BED populations.

Heterogeneity across studies - varying BMI, age, medication status, and ED severity - was significant enough to prevent a meta-analysis. This means we have consistent directional evidence but no pooled effect sizes. The female-heavy samples also limit how broadly we can generalise the findings.

What makes this review genuinely interesting is its relevance beyond the clinical ED population. Binge eating and sleep disruption are among the most prevalent and intertwined problems in the general population - particularly among younger adults under chronic stress. While not clinically diagnosed with eating disorders, many people experience the same bidirectional loop at a subclinical level: poor sleep drives appetite dysregulation, appetite dysregulation further fragments sleep. The study's framing of this as a shared biological system is a useful lens for thinking about sleep health more broadly.

From Our Formula Note

Reincarn Night Reboot™ - General Sleep Architecture Context

This study does not examine supplement interventions, and none of the ingredients in Reincarn Night Reboot™ are referenced in the review. Reincarn Night Reboot™ is a general sleep support supplement - it is not a treatment for eating disorders or any clinical condition. The context below describes how ingredients in the formula relate to the sleep architecture mechanisms this research documents, for educational purposes only.

The review documents three specific sleep architecture disruptions across ED populations: reduced slow-wave sleep, reduced REM sleep, and fragmented sleep with increased nighttime arousals. These are not unique to eating disorder populations - they are among the most common markers of poor sleep quality in general, and they are the architectural targets of several ingredients in the formula.

Glycine
3000 mg per sachet
Glycine has been shown to support slow-wave sleep quality and reduce daytime fatigue in clinical studies. It lowers core body temperature at sleep onset - the same circadian signal that initiates slow-wave sleep architecture.
Magnesium Bisglycinate
300 mg per sachet
Supports GABA synthesis and NMDA receptor regulation, facilitating the transition from wakefulness into deeper sleep stages. Low magnesium is associated with lighter, more fragmented sleep architecture.
KSM-66 Ashwagandha
300 mg per sachet
Studied for its effects on stress and cortisol - both of which are elevated in AN and contribute to the hyperarousal that fragments sleep. Positioned in this formula as the Stress Reset ingredient; not a sleep-onset agent.

Individual ingredients were tested in independent clinical studies. The 7-ingredient Reincarn Night Reboot™ formula has not been tested as a combined formulation in a single trial. This formula context is not a claim that Reincarn Night Reboot™ treats or is suitable for individuals with eating disorders. Anyone with a clinical eating disorder should work with their healthcare team.

Frequently Asked Questions

Do people with eating disorders sleep worse?
Yes. Across anorexia nervosa, bulimia nervosa, and binge-eating disorder, individuals consistently showed poorer sleep quality, longer sleep onset latency, and more fragmented sleep with increased nighttime arousals. Anorexia nervosa showed the most severe sleep abnormalities, with objectively measured reductions in REM and slow-wave sleep.
What is the connection between sleep and eating disorders?
The relationship is bidirectional and multifactorial. Disordered eating patterns, irregular meal timing, and altered energy availability disrupt circadian timing and sleep architecture. In turn, poor sleep - particularly reduced slow-wave sleep - alters the hormones governing hunger and satiety, which can worsen eating disorder symptoms. Orexin, which governs both wakefulness and feeding behaviour, is proposed as a key mechanistic link.
What is orexin and why does it matter here?
Orexin (also called hypocretin) is a neuropeptide produced in the hypothalamus that simultaneously promotes arousal, suppresses REM sleep, and regulates feeding and energy balance. Because it sits at the intersection of both sleep and appetite regulation, disruptions to orexin signalling - whether from caloric restriction, disordered eating timing, or metabolic changes - can cascade through both systems, disrupting sleep architecture and worsening appetite dysregulation.
Does this research apply to people without a clinical eating disorder?
The study focused on clinically diagnosed populations. However, the bidirectional mechanisms it describes - poor sleep disrupting appetite regulation, and disrupted eating disrupting circadian timing - are not exclusive to clinical EDs. Sleep-driven increases in ghrelin (hunger hormone) and decreases in leptin (satiety hormone) are well-documented in general population research. The orexin mechanism and the evening chronotype findings are relevant to understanding appetite dysregulation in broader contexts.
What were the main limitations of this review?
Three main limitations: first, most studies used subjective sleep measures rather than objective polysomnography, making it harder to confirm findings with high-quality data. Second, significant heterogeneity across studies (varying BMI, age, medication status) prevented a meta-analysis, so there are no pooled effect sizes. Third, samples were predominantly female, limiting generalisability. The review provides consistent directional evidence but stops short of definitive causal conclusions.

The Sleep Performance Digest

New peer-reviewed research on sleep, decoded and connected to your biology. One issue a week, no noise.

-R-
Reincarn Science Team
The REINCARN Science Team reviews peer-reviewed research on sleep, recovery, and performance. All analysis is for educational purposes. Content is reviewed for scientific accuracy and claims compliance before publication. About our science process.
Citation

Sleep, circadian rhythms and eating disorders: a systematic review. Frontiers in Neuroendocrinology. PMID: 42242323.

Educational content only. This article is published for informational and educational purposes and does not constitute medical advice. Reincarn Night Reboot™ is a food supplement, not a medicine, and is not intended to diagnose, treat, cure, or prevent any disease or medical condition. This article discusses research on eating disorder populations; Reincarn Night Reboot™ is not suitable for individuals with active eating disorders without healthcare supervision. Individual ingredients in Reincarn Night Reboot™ were tested in independent clinical studies; the 7-ingredient combined formula has not been tested in a single clinical trial. Contains KSM-66 Ashwagandha - consult a healthcare professional before use if you have a thyroid condition or are on thyroid medication. For adults 18 years and above. FSSAI Licensed. Published by Zandra Life Sciences Pvt. Ltd. COI disclosure: this article is published on the website of REINCARN, which markets Reincarn Night Reboot™. The science reviewed is independent peer-reviewed research. Corrections: science@reincarn.in.